vilin-bio-med-ltd

Home

Vilin Bio Med Ltd

Vilin Bio Med Ltd Financials

Vilin Bio Med Ltd Financial Statement

Vilin Bio Med Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Mar 2023	Dec 2022
Revenue	3.30	4.94
Operating Expense	3.06	3.69
Net Profit	-0.04	0.73
Net Profit Margin	-1.21	14.78
Earning Per Share	TBA	2.21
EBIDTA	0.24	1.22
Effective Tax Rate	29.17	22.40

Particulars	Mar 2023
Revenue	3.30
Operating Expense	3.06
Net Profit	-0.04
Net Profit Margin	-1.21
Earning Per Share	TBA
EBIDTA	0.24
Effective Tax Rate	29.17

Vilin Bio Med Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Total Revenue Annual	15.80	12.31	11.21
Operating Expenses Annual	14.99	9.74	10.45
Operating Profit Annual	1.14	2.60	0.77
Interest Annual	0.79	0.65	0.51
Depreciation	0.13	0.17	0.22
Net Profit Annual	0.16	1.25	0.03
Tax Annual	0.06	0.54	0.01

Particulars	Mar 2024
Total Revenue Annual	15.80
Operating Expenses Annual	14.99
Operating Profit Annual	1.14
Interest Annual	0.79
Depreciation	0.13
Net Profit Annual	0.16
Tax Annual	0.06

Vilin Bio Med Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Cash Flow at the Beginning	0.03	0.04	0.05
Cash Flow from Operations	-5.30	-1.66	0.21
Cash Flow from Investing	0.32	-0.03	TBA
Cash Flow from Financing	10.99	1.68	-0.22
Cash Flow at the End	6.05	0.03	0.04

Particulars	Mar 2024
Cash Flow at the Beginning	0.03
Cash Flow from Operations	-5.30
Cash Flow from Investing	0.32
Cash Flow from Financing	10.99
Cash Flow at the End	6.05

Vilin Bio Med Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
PBDIT Margin (%)	7.28	21.12	6.87
PBIT Margin (%)	6.46	19.74	4.91
PBT Margin (%)	-1.64	-10.72	-4.72
Net PROFIT Margin (%)	1.01	10.15	0.27
Return On Networth / Equity (%)	0.95	13.83	0.41
Return On Networth /Employed (%)	4.46	17.24	4.30
Return On Assets (%)	0.71	8.83	0.24
Total Debt / Equity (X)	0.35	0.57	0.73
Asset Turnover Ratio (%)	0.70	0.87	0.88

Particulars	Mar 2024
PBDIT Margin (%)	7.28
PBIT Margin (%)	6.46
PBT Margin (%)	-1.64
Net PROFIT Margin (%)	1.01
Return On Networth / Equity (%)	0.95
Return On Networth /Employed (%)	4.46
Return On Assets (%)	0.71
Total Debt / Equity (X)	0.35
Asset Turnover Ratio (%)	0.70

Vilin Bio Med Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Fixed Assets Annual	1.38	1.51	1.65
Total Current Assets Annual	18.62	8.05	11.91
Non Current Assets Annual	13.79	9.62	1.65
Total Shareholders Funds Annual	22.84	10.68	7.40
Total Assets Annual	32.40	17.68	13.56

Particulars	Mar 2024
Fixed Assets Annual	1.38
Total Current Assets Annual	18.62
Non Current Assets Annual	13.79
Total Shareholders Funds Annual	22.84
Total Assets Annual	32.40

Vilin Bio Med Ltd Earning Calls

No Data Availabe

Dividend Pages

PE Ratio

Get Your FAQs Right

As of Dec 11, 2024, Vilin Bio Med Ltd has a market capitalization of 26.51 Cr. Value Research classifies it as a Micro-Cap company.

Yes, Vilin Bio Med Ltd is debt-free with a debt-to-equity ratio of 0.30.

In FY 2023 , Vilin Bio Med Ltd recorded a total revenue of approximately 15.80 Cr marking a significant milestone in the company's financial performance.

Vilin Bio Med Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately Infinity% and 0.2% annually, respectively..

Vilin Bio Med Ltd's current PE ratio is 165.69.

Vilin Bio Med Ltd's ROCE averaged 7.8% from the FY ending March 2022 to 2024, with a median of 4.3%. It peaked at 15.6% in March 2023, reflecting strong capital efficiency over the period..

Vilin Bio Med Ltd's latest EBIT is Rs. 1.02 Cr, surpassing the average EBIT of Rs. 1.33 Cr over the 5 years..